Insider Transactions in Q4 2023 at Forte Biosciences, Inc. (FBRX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
10,000
+0.55%
|
$0
$0.75 P/Share
|
|
Dec 14
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
10,000
+0.55%
|
$0
$0.72 P/Share
|
|
Dec 13
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
10,520
+0.58%
|
$0
$0.7 P/Share
|
|
Dec 12
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
4,776
+0.27%
|
$0
$0.65 P/Share
|
|
Dec 11
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
25,000
+1.38%
|
$0
$0.65 P/Share
|
|
Dec 08
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
15,000
+0.84%
|
$0
$0.62 P/Share
|
|
Dec 07
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
36,203
+2.03%
|
$0
$0.58 P/Share
|
|
Nov 22
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
400
+0.02%
|
$0
$0.43 P/Share
|
|
Nov 20
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
6,966
+0.14%
|
$0
$0.43 P/Share
|
|
Oct 01
2023
|
Paul A. Wagner |
SELL
Payment of exercise price or tax liability
|
Direct |
2,453
-0.14%
|
$0
$0.66 P/Share
|
|
Oct 01
2023
|
Paul A. Wagner |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+1.8%
|
-
|
|
Oct 01
2023
|
Antony A Riley CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,241
-1.74%
|
$0
$0.66 P/Share
|
|
Oct 01
2023
|
Antony A Riley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+4.79%
|
-
|
|
Oct 01
2023
|
Hubert C Chen Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,593
-2.83%
|
$0
$0.66 P/Share
|
|
Oct 01
2023
|
Hubert C Chen Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.57%
|
-
|